Cases

Cost Effectiveness and Budget Impact
A large international pharmaceutical company was applying for the reimbursement of a new indication of an existing product.  As the reimbursement request was for an orphan drug, a cost-...
Curando Logo
A major change in the past year was the ‘Curando HOP’ project coached by hict, with the aim of harmonisation and optimisation of all the processes. In line with this project a second project...
Default Image - Pharma
Performing a health-economic evaluation (budget impact analysis) of a proposed adaptation of the reimbursement criteria for certain implants in Belgium.
Client logo for Vlaamse Logo's
Logo stands for LOkaal GezondheidsOverleg (local deliberation on health). Logos are geographically defined networks wherein different organisations collaborate to execute the Flemish preventive care...
Novartis logo
Novartis, a large international pharmaceutical company had applied for Class 1 reimbursement of Jakavi for adult patients with myelofibrosis.  The company asked hict for support...
Orion Logo
Orion  Orion is a Finnish, Espoo–based pharmaceutical company with branches across Europe. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical...
Logo_Curando
Curando offers her care in an integrated way in five care zones spread across West Flanders. The aim is to arrange the care zones according to six formulas allowing the organisation to provide full...
Logo az Glorieux
AZ Glorieux is a merged hospital since January 1st, 2013, as a result of the acquisition of the Aurora Hospital (campus Ronse). The hospital has 348 beds for acute stay and 56 day clinic beds. About...
Logo BD
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD wants to investigate the market interest...
Ezelstraat 69 | B- 8000 Brugge | Belgium | Phone: +32.50.33.33.40 | Fax: +32.50.33.33.39 | BTW BE 0866 039 556 | RPR/RPM Brugge | e-mail: info@hict.com